Overview
Eko Health is a pioneer in digital health, specializing in AI-driven cardiac and pulmonary monitoring. The platform leverages advanced digital stethoscopes, such as the CORE 500™ and CORE™ Attachment, paired with the SENSORA™ AI platform to transform traditional auscultation into a high-precision diagnostic tool. By 2026, Eko has established itself as the market leader in frontline cardiac screening, utilizing machine learning algorithms to detect structural heart murmurs, AFib, and Low Ejection Fraction (a key indicator of heart failure) with clinical-grade accuracy. The technical architecture involves 40x sound amplification, active noise cancellation, and integrated 3-lead ECG data processing. Data is transmitted via Bluetooth to the Eko App and stored in a HIPAA-compliant cloud, where AI models analyze the waveforms against a massive dataset of clinical recordings. Positioned as a bridge between primary care and cardiology, Eko reduces unnecessary specialist referrals while ensuring early intervention for critical conditions. The 2026 roadmap emphasizes deeper integration into health system EHRs and expanded pulmonary diagnostic capabilities for COPD and asthma monitoring.